CTOs on the Move

Temrex Corp

www.temrex.com

 
Temrex Corp is a Freeport, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.temrex.com
  • PO BOX 182
    Freeport, NY USA 11520
  • Phone: 516.868.6221

Executives

Name Title Contact Details

Similar Companies

Glytec System

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Lightning Step

Lightning Step is the only all-in-one enterprise software for behavioral health and addiction treatment centers created by treatment professionals. The solution brings together the fundamentals required to operate and grow a successful facility in today`s world, integrating CRM, EMR, and RCM systems and removing the cross-communication pain points of using multiple platforms. Enjoy a smoother operation with one system, one login, one price.

American Association of Nuerological Surgeons

American Association of Nuerological Surgeons is a Rolling Meadows, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.